vs

Side-by-side financial comparison of Perella Weinberg Partners (PWP) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

Perella Weinberg Partners is the larger business by last-quarter revenue ($219.2M vs $197.9M, roughly 1.1× REPLIGEN CORP). REPLIGEN CORP runs the higher net margin — 6.7% vs 6.3%, a 0.4% gap on every dollar of revenue. On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs -2.9%). Perella Weinberg Partners produced more free cash flow last quarter ($30.5M vs $17.6M). Over the past eight quarters, Perella Weinberg Partners's revenue compounded faster (46.5% CAGR vs 14.4%).

PJT Partners, Inc. is a global advisory-focused investment bank, founded in October 2015 as part of The Blackstone Group's spin-off of its financial and strategic advisory services businesses.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

PWP vs RGEN — Head-to-Head

Bigger by revenue
PWP
PWP
1.1× larger
PWP
$219.2M
$197.9M
RGEN
Growing faster (revenue YoY)
RGEN
RGEN
+16.5% gap
RGEN
13.6%
-2.9%
PWP
Higher net margin
RGEN
RGEN
0.4% more per $
RGEN
6.7%
6.3%
PWP
More free cash flow
PWP
PWP
$12.9M more FCF
PWP
$30.5M
$17.6M
RGEN
Faster 2-yr revenue CAGR
PWP
PWP
Annualised
PWP
46.5%
14.4%
RGEN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PWP
PWP
RGEN
RGEN
Revenue
$219.2M
$197.9M
Net Profit
$13.8M
$13.3M
Gross Margin
52.5%
Operating Margin
8.5%
9.0%
Net Margin
6.3%
6.7%
Revenue YoY
-2.9%
13.6%
Net Profit YoY
143.9%
EPS (diluted)
$0.11
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PWP
PWP
RGEN
RGEN
Q4 25
$219.2M
$197.9M
Q3 25
$164.6M
$188.8M
Q2 25
$155.3M
$182.4M
Q1 25
$211.8M
$169.2M
Q4 24
$225.7M
$174.1M
Q3 24
$278.2M
$154.9M
Q2 24
$272.0M
$154.1M
Q1 24
$102.1M
$151.3M
Net Profit
PWP
PWP
RGEN
RGEN
Q4 25
$13.8M
$13.3M
Q3 25
$6.0M
$14.9M
Q2 25
$2.7M
$14.9M
Q1 25
$17.3M
$5.8M
Q4 24
$-30.3M
Q3 24
$16.4M
$-654.0K
Q2 24
$-66.0M
$3.3M
Q1 24
$-35.8M
$2.1M
Gross Margin
PWP
PWP
RGEN
RGEN
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
PWP
PWP
RGEN
RGEN
Q4 25
8.5%
9.0%
Q3 25
5.4%
8.9%
Q2 25
5.8%
7.6%
Q1 25
5.5%
3.9%
Q4 24
-17.7%
Q3 24
12.9%
-5.1%
Q2 24
-30.2%
1.0%
Q1 24
-52.4%
1.3%
Net Margin
PWP
PWP
RGEN
RGEN
Q4 25
6.3%
6.7%
Q3 25
3.6%
7.9%
Q2 25
1.8%
8.2%
Q1 25
8.2%
3.4%
Q4 24
-17.4%
Q3 24
5.9%
-0.4%
Q2 24
-24.3%
2.2%
Q1 24
-35.1%
1.4%
EPS (diluted)
PWP
PWP
RGEN
RGEN
Q4 25
$0.11
$0.24
Q3 25
$0.08
$0.26
Q2 25
$0.04
$0.26
Q1 25
$0.24
$0.10
Q4 24
$-0.55
Q3 24
$0.24
$-0.01
Q2 24
$-1.21
$0.06
Q1 24
$-0.91
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PWP
PWP
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$255.9M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$-127.4M
$2.1B
Total Assets
$797.6M
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PWP
PWP
RGEN
RGEN
Q4 25
$255.9M
$767.6M
Q3 25
$185.5M
$748.7M
Q2 25
$145.0M
$708.9M
Q1 25
$111.2M
$697.2M
Q4 24
$407.4M
$757.4M
Q3 24
$335.1M
$784.0M
Q2 24
$185.3M
$809.1M
Q1 24
$156.7M
$780.6M
Total Debt
PWP
PWP
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
PWP
PWP
RGEN
RGEN
Q4 25
$-127.4M
$2.1B
Q3 25
$-302.4M
$2.1B
Q2 25
$-318.4M
$2.1B
Q1 25
$-323.1M
$2.0B
Q4 24
$-421.4M
$2.0B
Q3 24
$-360.8M
$2.0B
Q2 24
$-283.0M
$2.0B
Q1 24
$161.9M
$2.0B
Total Assets
PWP
PWP
RGEN
RGEN
Q4 25
$797.6M
$2.9B
Q3 25
$650.2M
$2.9B
Q2 25
$606.7M
$2.9B
Q1 25
$570.5M
$2.9B
Q4 24
$876.8M
$2.8B
Q3 24
$810.9M
$2.8B
Q2 24
$645.5M
$2.9B
Q1 24
$583.6M
$2.8B
Debt / Equity
PWP
PWP
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PWP
PWP
RGEN
RGEN
Operating Cash FlowLast quarter
$34.8M
$25.7M
Free Cash FlowOCF − Capex
$30.5M
$17.6M
FCF MarginFCF / Revenue
13.9%
8.9%
Capex IntensityCapex / Revenue
2.0%
4.1%
Cash ConversionOCF / Net Profit
2.52×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$-34.1M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PWP
PWP
RGEN
RGEN
Q4 25
$34.8M
$25.7M
Q3 25
$59.2M
$48.1M
Q2 25
$56.1M
$28.6M
Q1 25
$-176.5M
$15.0M
Q4 24
$223.4M
$39.2M
Q3 24
$200.3M
$49.3M
Q2 24
$90.0M
$42.2M
Q1 24
$-206.3M
$44.7M
Free Cash Flow
PWP
PWP
RGEN
RGEN
Q4 25
$30.5M
$17.6M
Q3 25
$57.6M
$43.4M
Q2 25
$55.3M
$21.5M
Q1 25
$-177.6M
$11.4M
Q4 24
$207.0M
$33.6M
Q3 24
$199.3M
$42.3M
Q2 24
$83.7M
$37.4M
Q1 24
$-214.8M
$36.4M
FCF Margin
PWP
PWP
RGEN
RGEN
Q4 25
13.9%
8.9%
Q3 25
35.0%
23.0%
Q2 25
35.6%
11.8%
Q1 25
-83.8%
6.8%
Q4 24
91.7%
19.3%
Q3 24
71.6%
27.3%
Q2 24
30.8%
24.3%
Q1 24
-210.3%
24.0%
Capex Intensity
PWP
PWP
RGEN
RGEN
Q4 25
2.0%
4.1%
Q3 25
0.9%
2.5%
Q2 25
0.5%
3.9%
Q1 25
0.5%
2.1%
Q4 24
7.3%
3.2%
Q3 24
0.4%
4.5%
Q2 24
2.3%
3.1%
Q1 24
8.3%
5.5%
Cash Conversion
PWP
PWP
RGEN
RGEN
Q4 25
2.52×
1.93×
Q3 25
9.85×
3.23×
Q2 25
20.50×
1.92×
Q1 25
-10.18×
2.57×
Q4 24
Q3 24
12.23×
Q2 24
12.70×
Q1 24
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons